Transcription of 2019 AFib Guidelines Made Simple Tool
{{id}} {{{paragraph}}}
Example: marketing
2019 AFib Guidelines Made Simple Tool
2019 AHA/ACC/HRS Focused Update of the 2014 Guideline for Management of Patients with Atrial FibrillationGUIDELINES MADE Simple - Focused Update EditionA Selection of Tables and Figures 2018, American College of Cardiology AHA/ACC/HRS Focused Update of the 2014 Guideline for Management of Patients with Atrial FibrillationA report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , and the Heart Rhythm SocietyCraig T. January, MD, PhD, FACC, ChairL. Samuel Wann, MD, MACC, FAHA, Vice Chair Hugh Calkins, MD, FACC, FAHA, FHRSLin Y. Chen, MD, MS, FACC, FAHA, FHRSJ oaquin E. Cigarroa, MD, FACCJ oseph C. Cleveland, Jr, MD, FACCP atrick T. Ellinor, MD, PhDMichael Exekowitz, MBChB, DPhil, FACC, FAHAM ichael E. field, MD, FACC, FAHA, FHRSK aren Furie, MD, MPH, FAHAPaul Heidenreich, MD, FACC, FAHAK atherine T. Murray, MD, FACC, FAHA, FHRSJ ulie B.
followed by long term anticoagulation therapy. For patients with AF or atrial flutter of 48 hours’ duration or longer, or when the duration of AF is unknown, anticoagulation with warfarin (INR 2.0 to 3.0), a factor Xa inhibitor, or direct thrombin inhibitor is recommended for at least 3 weeks before and at least 4 weeks after cardioversion.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: